Yumanity Therapeutics

Developer of therapeutics solutions for neurodegenerative diseases caused by protein misfolding

placeCambridge, Massachusetts, United States calendar_todayFounded 2014 groups40 employees language yumanity.com

Registered entities

Innovation

22 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities, Mechanical engineering; filing pace slowing. Cited 857 times.

YearFilings
20182
20198
202010
202116
20229
20238
20245

Investor mix

8 investors on record; lead investors include Fidelity Investments, Redmile Group, Alexandria, Biogen.

Investor typeCountShare
Venture capital338%
Other / undisclosed563%
Coming soon